Haleon (Haleon) Net Margin % : 14.49% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Haleon's Net Income for the three months ended in Mar. 2024 was $537 Mil. Haleon's Revenue for the three months ended in Mar. 2024 was $3,709 Mil. Therefore, Haleon's net margin for the quarter that ended in Mar. 2024 was 14.49%.

The historical rank and industry rank for Haleon's Net Margin % or its related term are showing as below:

HLN' s Net Margin % Range Over the Past 10 Years
Min: 7.72 Med: 9.76 Max: 14.56
Current: 9.64

HLN's Net Margin % is ranked better than
68.76% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.25 vs HLN: 9.64

Haleon Net Margin % Historical Data

The historical data trend for Haleon's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Net Margin % Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

7.72

11.58

14.56

9.76

9.28

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Margin %	Get a 7-Day Free Trial									13.03	10.83	13.05	-0.11	14.49

Competitive Comparison of Haleon's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haleon's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Net Margin % distribution charts can be found below:

* The bar in red indicates where Haleon's Net Margin % falls into.

Haleon Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Haleon's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	1327.848	/	14306.329
	=	9.28 %

Haleon's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin	=	Net Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	537.484	/	3709.022
	=	14.49 %

Haleon (NYSE:HLN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Haleon Net Margin % Related Terms

Thank you for viewing the detailed overview of Haleon's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (Haleon) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN1:Mexico HLNl:UK HLN:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.